⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
On March 20, 2026, the Indian patent for semaglutide (Novo Nordisk's Ozempic/Wegovy) expired. Within 24 hours, over 40 Indian pharmaceutical companies launched generic versions, causing prices to crash from ₹8,800/month to as low as ₹1,250/month.
Yes. Generic semaglutide contains the same active molecule as Ozempic/Wegovy. Indian generics must meet CDSCO (Central Drugs Standard Control Organisation) bioequivalence standards before approval. This means:
| Brand | Manufacturer | Price/month | Savings vs Ozempic |
|---|---|---|---|
| Ozempic (branded) | Novo Nordisk | ₹8,800 | — |
| Noveltreat | Sun Pharma | ₹1,745 | 80% |
| Semanat | Natco Pharma | ₹1,290 | 85% |
| Obeda | Dr Reddy's | ₹4,200 | 52% |
| Semaze | Zydus | ₹1,500 | 83% |
| Semaglu | Alkem | ₹1,250 | 86% |
Generic semaglutide offers the same clinical benefits at 50-86% lower cost. The choice between brands often comes down to availability, pen design preference, and your doctor's recommendation.
